Figure 2:
![Multispectral optoacoustic tomographic (MSOT) images from different commercially available optoacoustic (OA) medical imaging systems. Images were acquired noninvasively from patients with breast cancer (MSOT Acuity [iThera Medical] and Imagio [Seno Medical]) or from excised lymph nodes in patients with melanoma (Vevo LAZR [VisualSonics]). Each set of images exhibits US imaging, OA imaging, and the overlay of the two modalities. Adapted, with permission, from references 4 (MSOT Acuity), 9 (Imagio), and 10 (Vevo LAZR).](https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=7983661_rycan.2020200066.fig2.jpg)
Multispectral optoacoustic tomographic (MSOT) images from different commercially available optoacoustic (OA) medical imaging systems. Images were acquired noninvasively from patients with breast cancer (MSOT Acuity [iThera Medical] and Imagio [Seno Medical]) or from excised lymph nodes in patients with melanoma (Vevo LAZR [VisualSonics]). Each set of images exhibits US imaging, OA imaging, and the overlay of the two modalities. Adapted, with permission, from references 4 (MSOT Acuity), 9 (Imagio), and 10 (Vevo LAZR).